Skip to content

Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi

Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in 5 to 20 mm Renal Calculi, Efficacity Prospective Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01604304
Acronym
CALIX-1
Enrollment
30
Registered
2012-05-23
Start date
2012-05-31
Completion date
2014-02-28
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Shockwave Lithotripsy, Flexible Ureteroscopy

Keywords

stone, calculi, kidney, renal treatment, flexible ureteroscopy, extracoporeal shockwave lithotripsy, retrograde intra renal surgery

Brief summary

Flexible ureteroscopy is a recent procedure to treat renal stone. Extracorporeal shockwave lithotripsy was the gold standard treatment for calculi between 5 and 20 mm. In literature, the two procedures are available to treat these stones with a good stone free rate. There is no prospective randomized study comparing these two treatments. Our study will define with a good level of evidence which technique is the best with regard to the stone free rate, secondary procedure rate and adverse effect.

Interventions

Flexible ureteroscopy will be use for 120 min max to treat renal stone. Laser, access sheath, baskets can be use to perform the technique.

The lithotriptor is use with 1,1 Hz frequency and stop when patient get 1000 joules of energy or if there is a problem with tolerance of this treatment or if stone is broken

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with 5 to 20 mm renal stone * Age ≥ 18 years old * Patient agreement signed * BMI \< 35 * Contraception

Exclusion criteria

* Pregnancy * Severe musculoskeletal deformities * Renal artery or aorta aneurysm * Pacemaker * Anesthesia contra indication * Psychiatric trouble or law protection

Design outcomes

Primary

MeasureTime frameDescription
Stone free rateThree monthsRate of stone free patient or patient with residual fragment ≤ 3 mm, 3 months after the treatment evaluated, will be compare. This outcome is measured with a tomodensitometry and compares with pre treatment exams.

Secondary

MeasureTime frameDescription
Stone free rate in weight's sub group3 monthsEach arm wil be divise in 3 sub group based on body mass index (20 to 25, 25 to 30, 30 to 35). We'll compare rate of efficacity in each sub group
Stone free rate in sub group depending on stone diameters3 monthsEach arm wil be divise in 3 sub group based on calculi diameter (5 to 10mm, 10 to 15 and 15 to 20). We'll compare rate of efficacity in each sub group
Secondary procedure rate3 monthsIn each arm will be evaluate rate of secondary procedure needed to have the best stone free rate
Serious and non serious adverse events3 monthsIn each arm will be evaluate rate of adverse event, type, severity.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026